Evaluation of the risk factors for recurrence and the development of epilepsy in patients with febrile seizure

• Published in: Arquivos de neuro-psiquiatria Vol. 80; no. 8; pp. 779 - 785
• Main Authors: Civan, Ahmet Burak, Ekici, Arzu, Havali, Cengiz, Kiliç, Nevin, Bostanci, Muharrem
• Format: Journal Article
• Language: English; Portuguese
• Published: Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil Thieme Revinter Publicações Ltda 01.08.2022; Arquivos de Neuro-Psiquiatria; Academia Brasileira de Neurologia - ABNEURO; Academia Brasileira de Neurologia (ABNEURO)
• Subjects: Anticonvulsants - therapeutic use; Antiepileptic agents; Convulsions & seizures; Convulsões Febris; Drug development; EEG; Electroencephalography; Epilepsia; Epilepsy; Epilepsy - complications; Epilepsy - drug therapy; Febre; Fever; Humans; Infant; NEUROSCIENCES; Original; Original Article; Patients; PSYCHIATRY; Recorrência; Recurrence; Retrospective Studies; Risk Factors; Seizures; Seizures, Febrile; Seizures, Febrile - complications; Seizures, Febrile - diagnosis; Seizures, Febrile - drug therapy; Recorrência; Recurrence; Epilepsia; Convulsões Febris; Epilepsy; Seizures, Febrile; Fever; Febre
• ISSN: 0004-282X; 1678-4227; 1678-4227
• DOI: 10.1055/s-0042-1755202

Abstract Background  Although febrile seizure (FS) is generally considered benign and self-limiting, there are differences regarding the risk factors, the prognosis, and the development of epilepsy. Objective  To examine the clinical and sociodemographic characteristics of patients diagnosed with FS, and to determine the risks of recurrence and the development of epilepsy. Methods  Between 2015 and 2019, we performed a retrospective evaluation of 300 patients with FS followed for at least 24 months. Results  The first episode of FS was simple in 72.7% of the patients and complex in 27.3%, and it recurred in 40%. Age under 12 months in the first FS, complex FS, and neurodevelopmental delay were found to statistically increase the risk of recurrence ( p  < 0.05). A total of 7% of the patients developed epilepsy, and this rate was found to be higher in patients with neurodevelopmental delay and long-term use of antiepileptic drugs ( p  < 0.001). The development of epilepsy was also observed in 77.8% of the patients with abnormal electroencephalogram (EEG). Epilepsy developed more frequently in those with abnormal EEG ( p <0.001). Conclusions  Neurodevelopmental delay was an important risk factor for FS recurrence and the development of epilepsy. Abnormality in the EEG is an important risk factor for the development of epilepsy. We found that the long-term prophylactic treatment did not cause decreases in the recurrence of FS nor in the development of epilepsy.